TherapeuticsMD TXMD
NASDAQ TXMD
$1.80 -0.05 (-2.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Operating Interest Expenses (2018 - 2024)

Updated

TherapeuticsMD's Operating Interest Expenses came in at $3,000 for Q3 2024, down 85.0% from $20,000 a year earlier and down 40.0% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Operating Interest Expenses (2018 - 2024) Analysis & Trends

Over the trailing twelve months to Sep 30, 2024, TherapeuticsMD reported Operating Interest Expenses of $73,000, down 96.7% year-over-year; for FY2018, it was $4.68 million.

  • The Q3 2024 figure represents the lowest quarterly Operating Interest Expenses in data going back to Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 TherapeuticsMD 20.83 Mn 20.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3,000.00
Jun 30, 2024 5,000.00
Sep 30, 2023 20,000.00
Jun 30, 2023 45,000.00
Mar 31, 2023 50,000.00
Dec 31, 2018 2.09 Mn
Sep 30, 2018 2.05 Mn
Jun 30, 2018 531,382.00
API Access

TherapeuticsMD Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=TXMD&period=max&api_key=YOUR_API_KEY